Stock Events

Emcure Pharmaceuticals 

₹1,381.5
8
-₹13.2-0.95% Wednesday 10:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
270.98B
P/E Ratio
54.29
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27NovExpected
Q2 2024
Next
7.64
8.04
8.43
8.83
Expected EPS
8.8295674236
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EMCURE.NSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Show more...
CEO
Mr. Satish Ramanlal Mehta
Country
IN
ISIN
INE168P01015

Listings